Renown Regional Medical Center

Renown Regional Medical Center was paid $63.69M by Medicaid between Jan 2018 and Dec 2024, across 633 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.

33Billing provider infoRENOWN REGIONAL MEDICAL CENTER
RENO, NV 89502

33aNPI1124098421assigned 01/26/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$63.69M

24GClaims3,397,789

24DCodes billed633

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Nevada

Rank by total paid#3 of 36

Median peer was paid$7.64M

This provider vs. median8.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MOORE, BRETT controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	281,457	$4.11M
2019	536,356	$9.94M
2020	499,527	$9.23M
2021	542,326	$9.96M
2022	527,356	$10.66M
2023	532,252	$10.35M
2024incomplete	478,515	$9.44M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	14%	96,776	81,530	$9.18M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	13%	54,201	44,188	$8.07M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.6%	68,753	60,591	$3.58M
G0378	Hospital observation service, per hour	5.2%	18,638	14,610	$3.28M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.4%	60,646	54,225	$2.78M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.4%	13,267	11,857	$2.19M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	2.5%	28,273	24,914	$1.56M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	2.0%	10,418	5,521	$1.30M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.4%	44,908	36,803	$873K
J9271	Injection, pembrolizumab, 1 mg	1.4%	168	106	$860K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.2%	2,125	1,882	$789K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.2%	22,679	20,711	$764K

621 more codes

96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	22,074	$751K
41899	Unlisted procedure, dentoalveolar structures	1.2%	1,195	$749K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.1%	3,273	$694K
70450	Computed tomography, head or brain; without contrast material	<1%	15,419	$635K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	28,880	$615K
80053	Comprehensive metabolic panel	<1%	164,798	$587K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,857	$558K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	6,746	$524K
90378		<1%	1,284	$503K
96375	Therapeutic injection; each additional sequential IV push	<1%	45,511	$484K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	22,368	$460K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	36,472	$442K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	23,878	$430K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	21,970	$428K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	8,113	$424K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,734	$420K
78815	Positron emission tomography (PET) for limited area imaging	<1%	689	$405K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	21,970	$396K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	20,954	$386K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,521	$386K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	164,805	$369K
72125	Computed tomography, cervical spine; without contrast material	<1%	5,033	$367K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,284	$359K
59025	Fetal non-stress test	<1%	10,167	$355K
47562		<1%	281	$335K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,947	$334K
76830	Ultrasound, transvaginal	<1%	4,581	$321K
58661		<1%	381	$319K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,589	$316K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,825	$315K
99214	Doctor's office visit, returning patient (more involved)	<1%	4,741	$310K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	5,905	$305K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	20,007	$289K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	15,256	$271K
70496		<1%	1,491	$255K
70498		<1%	1,426	$252K
84443	Thyroid stimulating hormone (TSH)	<1%	39,333	$248K
71045	Radiologic examination, chest; single view	<1%	44,020	$244K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	54,050	$226K
64615		<1%	868	$224K
70486		<1%	2,303	$214K
77066	Tomosynthesis, mammo	<1%	1,536	$205K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,290	$199K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	301	$192K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,390	$182K
77334		<1%	509	$182K
72131		<1%	2,722	$181K
95819		<1%	607	$170K
36415	Collection of venous blood by venipuncture	<1%	195,621	$170K
72141		<1%	1,562	$168K
90677		<1%	690	$156K
76801		<1%	3,442	$154K
93971		<1%	3,513	$152K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,971	$152K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,830	$150K
90791	Psychiatric diagnostic evaluation	<1%	5,801	$150K
J2505	Injection, pegfilgrastim, 6 mg	<1%	79	$145K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	8,065	$143K
0450	Emergency room services	<1%	3,119	$140K
95816		<1%	544	$139K
80061	Lipid panel	<1%	34,808	$138K
72128		<1%	1,852	$126K
76536		<1%	1,706	$126K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	11,033	$124K
99203	Doctor's office visit, new patient (routine)	<1%	2,947	$123K
77386		<1%	687	$123K
71250		<1%	1,624	$122K
10060		<1%	1,419	$120K
71046	Radiologic examination, chest; 2 views	<1%	9,443	$111K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	3,488	$109K
86900		<1%	12,302	$108K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,909	$105K
36430		<1%	1,397	$105K
84484		<1%	34,951	$102K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,388	$101K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	254	$99K
83690		<1%	37,703	$95K
76642		<1%	3,018	$94K
80074		<1%	2,798	$94K
96376		<1%	16,555	$94K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	2,125	$90K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	2,956	$90K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,825	$89K
83036	Hemoglobin; glycosylated (A1C)	<1%	34,245	$87K
87086	Culture, bacterial; quantitative colony count, urine	<1%	28,815	$84K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	4,967	$83K
86780		<1%	13,520	$81K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	11,665	$78K
87660		<1%	9,396	$78K
83880		<1%	9,004	$78K
70491		<1%	740	$78K
90715		<1%	5,137	$77K
87150		<1%	3,966	$76K
J7030	Infusion, normal saline solution , 1000 cc	<1%	63,924	$75K
87510		<1%	9,396	$73K
87480		<1%	9,396	$73K
93970		<1%	1,230	$72K
76775		<1%	2,721	$71K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	942	$70K
80048	Basic metabolic panel (calcium, ionized)	<1%	33,478	$69K
84703		<1%	23,172	$66K
12011		<1%	1,563	$65K
12001		<1%	1,756	$62K
74018		<1%	5,626	$62K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,454	$62K
96415		<1%	3,497	$62K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,823	$61K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	6,052	$59K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	110	$58K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,471	$58K
83970		<1%	2,586	$58K
73610		<1%	3,792	$57K
85027		<1%	33,770	$57K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,099	$55K
73630		<1%	3,782	$55K
86480		<1%	1,709	$54K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	8,338	$53K
96417		<1%	2,834	$51K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	189	$50K
73130		<1%	3,244	$50K
57265		<1%	67	$49K
73700		<1%	577	$48K
86803		<1%	8,636	$48K
84702		<1%	9,081	$47K
73564		<1%	2,425	$47K
73030		<1%	3,877	$47K
97602		<1%	2,977	$45K
72100		<1%	3,053	$45K
87186		<1%	12,608	$45K
87040		<1%	14,928	$45K
84403		<1%	2,613	$43K
83605		<1%	13,770	$43K
73110		<1%	2,374	$42K
74183		<1%	153	$41K
87077		<1%	17,919	$41K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	29,464	$40K
90686		<1%	9,560	$40K
76870		<1%	1,232	$40K
81001		<1%	37,446	$39K
77065	Tomosynthesis, mammo	<1%	403	$38K
87070		<1%	9,926	$38K
84439		<1%	18,802	$36K
82607		<1%	9,182	$36K
82728		<1%	8,327	$36K
97597		<1%	3,577	$36K
96367		<1%	4,567	$35K
88307		<1%	2,168	$34K
73562		<1%	2,124	$34K
80050	General health panel	<1%	779	$34K
87522	Neg quan hep c or qual rna	<1%	1,492	$33K
12002		<1%	823	$33K
73221		<1%	242	$32K
29125		<1%	1,085	$32K
93017		<1%	2,758	$32K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	20,554	$32K
74240		<1%	415	$32K
82077		<1%	7,259	$32K
44970		<1%	32	$31K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	52	$30K
85610		<1%	31,466	$29K
77080		<1%	1,599	$29K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	332	$29K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,116	$29K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	894	$29K
0240U		<1%	1,973	$28K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	411	$28K
72156		<1%	167	$26K
J8597	Antiemetic drug, oral, not otherwise specified	<1%	17,888	$26K
36591		<1%	3,808	$26K
83735		<1%	19,960	$26K
77412		<1%	233	$26K
74175		<1%	161	$25K
84145		<1%	3,603	$25K
86762		<1%	3,968	$24K
97165		<1%	1,887	$23K
77336		<1%	1,780	$23K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	119	$22K
73080		<1%	1,341	$22K
85730		<1%	14,753	$22K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,653	$22K
73590		<1%	1,953	$22K
97161		<1%	1,772	$22K
99152		<1%	3,088	$21K
81025		<1%	11,340	$21K
87340		<1%	5,885	$21K
72040		<1%	1,467	$21K
83013		<1%	475	$20K
72110		<1%	781	$20K
99070		<1%	1,246	$20K
86235		<1%	1,017	$20K
73090		<1%	1,480	$19K
96409		<1%	341	$19K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	12,758	$19K
97162		<1%	1,292	$19K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	2,839	$19K
86140		<1%	12,073	$19K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	818	$19K
85379		<1%	5,353	$18K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	36,290	$18K
73140		<1%	976	$18K
72170		<1%	1,652	$17K
94010		<1%	530	$16K
94060		<1%	418	$16K
72158		<1%	78	$16K
84481		<1%	2,184	$16K
82746		<1%	5,126	$16K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,905	$16K
86850		<1%	12,002	$16K
81003		<1%	21,430	$16K
J3490	Unclassified drugs	<1%	10,897	$16K
J1170	Injection, hydromorphone, up to 4 mg	<1%	12,126	$16K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	276	$15K
57288		<1%	31	$15K
90732		<1%	358	$15K
J9312	Injection, rituximab, 10 mg	<1%	38	$15K
84153		<1%	2,139	$15K
87081		<1%	4,531	$15K
69210		<1%	674	$15K
99199	Unlisted special service, procedure or report	<1%	298	$15K
82784		<1%	3,169	$14K
82570		<1%	13,200	$14K
J0897	Injection, denosumab, 1 mg	<1%	73	$14K
76819	Fetal biophysical profile; without non-stress testing	<1%	373	$14K
81511		<1%	1,257	$14K
86901		<1%	15,437	$14K
82670		<1%	633	$14K
82962		<1%	30,341	$14K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	52,935	$13K
94726		<1%	367	$13K
73502		<1%	893	$13K
86003		<1%	422	$13K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,165	$13K
73560		<1%	1,168	$12K
83550		<1%	7,609	$12K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	32,584	$12K
84146		<1%	1,487	$12K
74019		<1%	819	$12K
77300		<1%	279	$12K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	9,292	$12K
49083		<1%	91	$11K
83540		<1%	8,868	$11K
86038		<1%	2,983	$11K
96523		<1%	1,279	$10K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,077	$10K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	10,981	$10K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	4,510	$10K
84425		<1%	1,691	$10K
84207		<1%	887	$10K
81002		<1%	9,677	$10K
83001		<1%	1,489	$10K
J2704	Injection, propofol, 10 mg	<1%	19,087	$10K
82043		<1%	7,992	$10K
84402		<1%	1,170	$9K
83516		<1%	2,720	$9K
82803		<1%	1,537	$9K
82105		<1%	1,217	$9K
83002		<1%	1,301	$8K
93922		<1%	272	$8K
97535	Self-care/home management training, each 15 minutes	<1%	1,166	$8K
88342		<1%	823	$8K
93880		<1%	160	$8K
11043		<1%	62	$8K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	2,851	$8K
54161		<1%	17	$8K
85055		<1%	1,216	$8K
80081		<1%	161	$8K
J0690	Injection, cefazolin sodium, 500 mg	<1%	16,985	$8K
84270		<1%	1,157	$8K
82950		<1%	3,400	$8K
85652		<1%	11,371	$8K
82274		<1%	1,249	$7K
64445		<1%	28	$7K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	6,906	$7K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,127	$7K
84100		<1%	8,970	$7K
85007		<1%	8,098	$7K
70487		<1%	71	$7K
99153	Mod sedat endo service >5yrs	<1%	1,718	$7K
94760		<1%	8,209	$7K
A4212	Non-coring needle or stylet with or without catheter	<1%	6,468	$7K
82550		<1%	4,017	$7K
94799		<1%	105	$7K
80143		<1%	1,373	$7K
95249		<1%	502	$6K
96411		<1%	512	$6K
97166		<1%	463	$6K
87493		<1%	442	$6K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	354	$6K
J7050	Infusion, normal saline solution, 250 cc	<1%	9,302	$6K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	27,255	$6K
72197		<1%	18	$6K
80179		<1%	1,178	$6K
82140		<1%	1,557	$6K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,958	$6K
82533		<1%	1,246	$5K
J2323	Injection, natalizumab, 1 mg	<1%	25	$5K
90656		<1%	470	$5K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	12,256	$5K
73100		<1%	381	$5K
86376		<1%	1,343	$5K
80069		<1%	1,759	$5K
73552		<1%	414	$5K
87205		<1%	5,705	$5K
86706		<1%	1,551	$5K
84156		<1%	5,065	$5K
99204	Doctor's office visit, new patient (more involved)	<1%	76	$4K
80076		<1%	1,659	$4K
84550		<1%	3,904	$4K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	199	$4K
72050		<1%	191	$4K
86923		<1%	767	$4K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	7,628	$4K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	283	$4K
90670		<1%	5,961	$4K
J1630	Injection, haloperidol, up to 5 mg	<1%	4,955	$4K
83655		<1%	585	$4K
84252		<1%	611	$4K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,905	$4K
86800		<1%	1,021	$4K
86704		<1%	1,080	$4K
73620		<1%	374	$4K
89060		<1%	1,093	$4K
J2060	Injection, lorazepam, 2 mg	<1%	7,444	$4K
99406		<1%	791	$4K
J1644	Injection, heparin sodium, per 1000 units	<1%	8,975	$4K
86364		<1%	1,220	$4K
87899		<1%	818	$4K
82330		<1%	1,549	$4K
71101		<1%	210	$4K
72070		<1%	239	$4K
86160		<1%	1,518	$4K
88142		<1%	360	$4K
83993		<1%	335	$4K
82010		<1%	1,252	$3K
83525		<1%	791	$3K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	4,778	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	11,896	$3K
80164		<1%	1,047	$3K
86200		<1%	753	$3K
84480		<1%	1,121	$3K
83615		<1%	2,215	$3K
77295		<1%	12	$3K
T1999	Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks"	<1%	250	$3K
94729		<1%	386	$3K
82378		<1%	652	$3K
76885		<1%	26	$3K
84112		<1%	424	$3K
88304		<1%	2,435	$3K
80055		<1%	107	$3K
95886		<1%	96	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	4,404	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	5,203	$3K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	309	$3K
88341		<1%	420	$3K
77280		<1%	49	$3K
11045		<1%	263	$3K
72157		<1%	31	$3K
72081		<1%	143	$3K
82951		<1%	409	$3K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,561	$3K
78264		<1%	12	$3K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	4,450	$3K
84134		<1%	772	$3K
83520		<1%	687	$3K
86431		<1%	1,847	$3K
82731		<1%	163	$3K
0250		<1%	847	$3K
74022		<1%	171	$3K
51798		<1%	796	$3K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	114	$3K
82024		<1%	104	$2K
87807		<1%	415	$2K
73060		<1%	256	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	162	$2K
92250		<1%	59	$2K
73501		<1%	224	$2K
86592		<1%	1,061	$2K
80197		<1%	508	$2K
87529		<1%	137	$2K
87641		<1%	211	$2K
96368		<1%	748	$2K
84466		<1%	706	$2K
86225		<1%	524	$2K
87045		<1%	623	$2K
92610		<1%	89	$2K
82977		<1%	1,275	$2K
12013		<1%	58	$2K
84630		<1%	596	$2K
82565		<1%	2,184	$2K
87075		<1%	818	$2K
36592		<1%	110	$2K
85018		<1%	3,208	$2K
74181		<1%	13	$2K
82248		<1%	1,229	$2K
85014		<1%	3,184	$2K
J1750	Injection, iron dextran, 50 mg	<1%	12	$2K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	19,505	$2K
85046		<1%	1,568	$2K
96127		<1%	342	$2K
97802		<1%	140	$2K
73070		<1%	177	$2K
84305		<1%	166	$2K
J1940	Injection, furosemide, up to 20 mg	<1%	1,489	$2K
72072		<1%	77	$2K
72146		<1%	13	$2K
73521		<1%	66	$2K
82652		<1%	46	$2K
93246		<1%	167	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	63	$1K
86141		<1%	348	$1K
73600		<1%	160	$1K
95250		<1%	13	$1K
87400		<1%	328	$1K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,623	$1K
96158		<1%	243	$1K
93325		<1%	147	$1K
G0008	Administration of influenza virus vaccine	<1%	1,420	$1K
J3360	Injection, diazepam, up to 5 mg	<1%	276	$1K
29105		<1%	16	$1K
84165		<1%	578	$1K
87046		<1%	341	$1K
J1953	Injection, levetiracetam, 10 mg	<1%	291	$1K
82247		<1%	456	$1K
87486		<1%	77	$1K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	746	$1K
99195		<1%	16	$1K
97163		<1%	48	$996.33
93308		<1%	13	$981.49
87581		<1%	77	$957.60
86341		<1%	94	$953.40
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	1,569	$943.87
82785		<1%	190	$904.22
87653		<1%	62	$903.98
89051		<1%	700	$894.97
84681		<1%	128	$877.64
86304		<1%	91	$868.91
Q0111	Wet mounts, including preparations of vaginal, cervical or skin specimens	<1%	1,351	$844.44
88312		<1%	282	$833.58
10005		<1%	13	$803.03
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	241	$792.46
77073		<1%	26	$728.58
J9190	Injection, fluorouracil, 500 mg	<1%	247	$693.14
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	198	$690.59
29515		<1%	15	$675.58
74220		<1%	15	$666.81
C1729	Catheter, drainage	<1%	1,044	$660.30
64400		<1%	16	$629.34
69209		<1%	77	$613.98
86258		<1%	253	$601.03
97605		<1%	49	$551.98
82952		<1%	305	$546.13
77077		<1%	18	$536.42
84460		<1%	346	$520.05
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,275	$518.62
99177		<1%	146	$508.11
77470		<1%	14	$491.50
87328		<1%	109	$488.03
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	35	$487.56
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	204	$484.45
87631		<1%	1,789	$476.76
C9113	Injection, pantoprazole sodium, per vial	<1%	383	$476.06
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	165	$460.84
J3411	Injection, thiamine hcl, 100 mg	<1%	215	$447.00
96159		<1%	153	$443.55
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	29	$433.18
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	76	$430.91
86147		<1%	24	$419.51
51702		<1%	50	$398.58
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	48	$396.84
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	444	$395.33
J9370	Vincristine sulfate, 1 mg	<1%	122	$387.72
73660		<1%	26	$385.80
87329		<1%	96	$377.61
84450		<1%	239	$354.34
70360		<1%	30	$332.47
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	671	$328.20
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	370	$320.70
0031A		<1%	19	$320.04
86308		<1%	122	$315.43
85384		<1%	117	$312.58
88112		<1%	43	$310.68
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	18	$307.86
82150		<1%	158	$295.57
84520		<1%	328	$284.98
80177		<1%	87	$283.12
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	155	$281.52
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	12	$278.41
82107		<1%	27	$267.08
70355		<1%	56	$262.35
88313		<1%	20	$255.15
83883		<1%	72	$254.23
83521		<1%	143	$250.07
87420		<1%	105	$246.28
73000		<1%	18	$245.52
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	122	$216.80
90744		<1%	2,787	$210.75
88300		<1%	548	$208.71
86665		<1%	26	$205.20
90621		<1%	78	$203.43
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,638	$203.17
87102		<1%	109	$200.91
82627		<1%	26	$196.50
J1171	Injection, hydromorphone, 0.1 mg	<1%	287	$190.01
94664		<1%	65	$185.28
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	41	$185.00
86039		<1%	59	$175.26
86162		<1%	12	$162.96
64447		<1%	45	$161.22
88360		<1%	25	$158.76
84155		<1%	518	$157.15
85347		<1%	136	$156.50
92558		<1%	144	$149.77
G0475	Hiv antigen/antibody, combination assay, screening	<1%	294	$143.56
90698		<1%	4,307	$142.35
83021		<1%	15	$142.09
84144		<1%	14	$137.06
0042T		<1%	119	$134.72
85520		<1%	61	$133.95
87338		<1%	13	$127.63
73120		<1%	16	$124.80
82272		<1%	140	$123.72
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,252	$123.51
86593		<1%	56	$122.94
C1781	Mesh (implantable)	<1%	277	$119.93
96161		<1%	131	$118.62
86787		<1%	32	$115.36
J0640	Injection, leucovorin calcium, per 50 mg	<1%	56	$111.43
J2470	Injection, pantoprazole sodium, 40 mg	<1%	75	$109.84
90662		<1%	712	$102.27
97116		<1%	40	$100.24
93280		<1%	12	$99.56
88302		<1%	312	$96.80
J1815	Injection, insulin, per 5 units	<1%	1,062	$91.69
82040		<1%	206	$90.54
C1769	Guide wire	<1%	3,058	$80.60
88720		<1%	27	$79.54
87076		<1%	61	$77.28
90710		<1%	1,909	$70.05
85049		<1%	68	$68.18
J7510	Prednisolone oral, per 5 mg	<1%	32	$65.56
82103		<1%	13	$64.19
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	54	$60.51
J2800	Injection, methocarbamol, up to 10 ml	<1%	25	$58.80
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	755	$56.08
80178		<1%	26	$55.75
84132		<1%	191	$50.24
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	98	$47.00
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	19,453	$46.23
84478		<1%	55	$45.79
90633		<1%	2,654	$44.26
84436		<1%	26	$42.21
86015		<1%	12	$40.32
87147		<1%	41	$37.73
83519		<1%	17	$36.88
83695		<1%	14	$35.24
72020		<1%	20	$33.30
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	<1%	381	$33.05
G0009	Administration of pneumococcal vaccine	<1%	322	$32.44
A9576	Injection, gadoteridol, (prohance multipack), per ml	<1%	747	$30.50
84300		<1%	31	$26.56
84160		<1%	75	$24.71
80047		<1%	55	$23.74
89055		<1%	13	$23.28
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	13	$22.39
90723		<1%	128	$22.01
J9263	Injection, oxaliplatin, 0.5 mg	<1%	72	$16.49
81050		<1%	14	$16.40
83721		<1%	26	$15.69
0270		<1%	22	$15.56
94761		<1%	38	$13.53
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	178	$12.81
88311		<1%	48	$12.51
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	151	$12.46
A9270	Non-covered item or service	<1%	119,849	$12.45
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	14	$11.30
87015		<1%	13	$9.12
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	1,138	$8.21
J1836	Injection, metronidazole, 10 mg	<1%	74	$7.62
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	51	$7.56
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	84	$5.61
A6403	Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	56	$4.19
A6402	Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	1,363	$3.99
A6454	Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard	<1%	350	$3.96
90651		<1%	1,095	$3.42
90696		<1%	649	$3.28
90734		<1%	554	$1.93
90685		<1%	699	$1.38
90680		<1%	3,691	$1.00
90707		<1%	191	$0.77
90716		<1%	186	$0.72
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	536	$0.68
90700		<1%	853	$0.29
90648		<1%	704	$0.04
91303		<1%	17	$0.02
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	13	$0.01
90647		<1%	215	$0.01
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	388	$0.00
00170	Anesthesia for intraoral procedures, including biopsy	0%	111	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	2,009	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	90	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	418	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	69	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	2,602	$0.00
99001		0%	99	$0.00
A4314	Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)	0%	34	$0.00
C1771	Repair device, urinary, incontinence, with sling graft	0%	82	$0.00
95708		0%	29	$0.00
91300		0%	14	$0.00
01922		0%	26	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	96	$0.00
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	0%	550	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	304	$0.00
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	0%	65	$0.00
A6223	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing	0%	43	$0.00
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	0%	36	$0.00
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	0%	92	$0.00
A4648	Tissue marker, implantable, any type, each	0%	43	$0.00
95700		0%	18	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	299	$0.00
90697		0%	77	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	61	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOORE, BRETT (CFO ACUTE CARE)

Same official

Other billing entities under MOORE, BRETT

Full network →

Provider	Location	Paid
Community Care Services LLC	Reno, NV	$15.07M
Renown South Meadows Medical Center	Reno, NV	$7.26M
Renown Medical School Associates North, INC.	Reno, NV	$5.43M
Community Care Services LLC	Reno, NV	$3.79M
Community Care Services LLC	Reno, NV	$2.60M
Hometown Health Management Company	Reno, NV	$1.69M
Eastern Sierra Medical Group LLC	Silver Springs, NV	$1.08M
Community Care Services LLC	Reno, NV	$1.07M
Community Care Services LLC	Reno, NV	$1.04M
Hometown Health Management Company	Sparks, NV	$849K
Community Care Services LLC	Fernley, NV	$845K
Renown Regional Medical Center	Reno, NV	$677K
Community Care Services LLC	Reno, NV	$530K
Community Care Services LLC	Reno, NV	$455K
Renown Transitional Care Services	Reno, NV	$420K
Community Care Services LLC	Reno, NV	$331K
Community Care Services LLC	Reno, NV	$293K
Community Care Services LLC	Reno, NV	$225K
Community Care Services LLC	Reno, NV	$102K
Community Care Services LLC	Reno, NV	$76K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.